Christopher A Caldwell Concentrix Corp (CNXC) insider trading activity

Christopher A Caldwell is President and CEO of Concentrix Corp. Currently has a direct ownership of 305,345 shares of CNXC, which is worth approximately $14.1 Million. The most recent transaction as insider was on Oct 10, 2025, when has been sold 1,000 shares (Common Stock) at a price of $45.35 per share, resulting in proceeds of $45,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 305K

0.65% 3M change

26.45% 12M change

Total Value Held $14.1 Million

Christopher A Caldwell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 10 2025	BUY Open market or private purchase	$45,350 $45.35 p/Share	1,000 Added 0.33%	305,345 Common Stock
Oct 07 2025	SELL Payment of exercise price or tax liability	$18,626 $47.76 p/Share	390 Reduced 0.13%	304,345 Common Stock
Sep 30 2025	SELL Payment of exercise price or tax liability	$429,991 $47.83 p/Share	8,990 Reduced 2.87%	304,735 Common Stock
Sep 30 2025	BUY Exercise of conversion of derivative security	$416,840 $44.52 p/Share	9,363 Added 2.9%	313,725 Common Stock
Sep 30 2025	BUY Open market or private purchase	$47,440 $47.44 p/Share	1,000 Added 0.33%	304,362 Common Stock
Apr 21 2025	BUY Open market or private purchase	$46,000 $46.0 p/Share	1,000 Added 0.33%	303,362 Common Stock
Feb 01 2025	SELL Payment of exercise price or tax liability	$255,021 $52.28 p/Share	4,878 Reduced 1.59%	302,362 Common Stock
Jan 29 2025	SELL Payment of exercise price or tax liability	$75,867 $53.96 p/Share	1,406 Reduced 0.46%	307,240 Common Stock
Jan 29 2025	BUY Grant, award, or other acquisition	-	5,774 Added 1.84%	308,646 Common Stock
Jan 27 2025	SELL Payment of exercise price or tax liability	$79,729 $53.51 p/Share	1,490 Reduced 0.49%	302,872 Common Stock
Jan 26 2025	SELL Payment of exercise price or tax liability	$58,687 $52.54 p/Share	1,117 Reduced 0.37%	304,362 Common Stock
Jan 24 2025	BUY Grant, award, or other acquisition	-	70,574 Added 18.77%	305,479 Common Stock
Dec 01 2024	SELL Payment of exercise price or tax liability	$295,501 $44.95 p/Share	6,574 Reduced 2.72%	234,905 Common Stock
Oct 07 2024	SELL Payment of exercise price or tax liability	$18,686 $51.62 p/Share	362 Reduced 0.15%	241,479 Common Stock
Oct 04 2024	SELL Open market or private sale	$517,672 $52.7 p/Share	9,823 Reduced 3.9%	241,841 Common Stock
Oct 04 2024	BUY Exercise of conversion of derivative security	$405,809 $31.39 p/Share	12,928 Added 4.89%	251,664 Common Stock
Oct 02 2024	SELL Payment of exercise price or tax liability	$20,266 $51.7 p/Share	392 Reduced 0.16%	238,736 Common Stock
Apr 19 2024	BUY Open market or private purchase	$49,131 $54.59 p/Share	900 Added 0.37%	239,128 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	40,322 Added 14.48%	238,228 Common Stock
Jan 27 2024	SELL Payment of exercise price or tax liability	$137,378 $92.2 p/Share	1,490 Reduced 0.75%	197,906 Common Stock
Jan 26 2024	SELL Payment of exercise price or tax liability	$97,091 $91.08 p/Share	1,066 Reduced 0.53%	199,396 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$621,440 $94.53 p/Share	6,574 Reduced 3.18%	200,462 Common Stock
Oct 11 2023	SELL Payment of exercise price or tax liability	$46,973 $82.41 p/Share	570 Reduced 0.27%	207,036 Common Stock
Oct 07 2023	SELL Payment of exercise price or tax liability	$29,141 $80.5 p/Share	362 Reduced 0.17%	207,606 Common Stock
Oct 02 2023	SELL Payment of exercise price or tax liability	$31,473 $80.29 p/Share	392 Reduced 0.19%	207,968 Common Stock

Also insider at

SNX

TD SYNNEX CORP Technology

President, Concentrix

CAC